top of page

Pediatric Stroke

Stroke Subtypes

​

  • Arterial Ischemic Infarction (AIS)

  • Cerebral Sinovenous Thrombosis (CSVT)

  • Hemorrhagic stroke (e.g. intracranial hemorrhage)

 

​

​

Perinatal and Perinatal Stroke (AIS)

​

  • Definition - AIS in a child from birth (28 weeks gestation) – 28 days of age

  • Etiology   - Unknown, likely multifactorial

    • 85% born at term

  • Prevalence -Rate 1/2000-5000 births

  • Presentation:

    • Seizure (neonate)

    • Hemiparesis or early handedness ( at ~ 5 months for presumed perinatal)

​

​

Presenting symptoms for pediatric stroke (AIS)

​

  • Hemiparesis (~50%)

  • Seizure (~50%)

  • Speech disturbance (~20%)

 

High Risk Populations

​

  • Congenital heart disease

  • Sickle cell disease

  • Down’s syndrome

  • Complex medical disorders

  • ECMO/VAD

  • Acute critical illness

  • Neonates

  • Head and neck infections

  • Trauma

​

​

Stroke Mimics

​

  • Hemiplegic migraine

  • Todd’s paralysis

  • Spinal cord disease (e.g. AFM)

  • PRES

  • MTX toxicity

  • Musculoskeletal disorder

  • Conversion disorder

  • ADEM

  • CNS infection

  • CNS neoplasm

 

Differential diagnosis for hemiparesis:

​

 Stroke (AIS)

  • Acute onset (sudden, abrupt)

  • Symptoms localize to a vascular territory  (e.g. ipsilateral face, arm, leg)

  • Painless gait disturbance

  • Typically without MS change

  • Low tone, normal of decreased reflexes

​

Musculoskeletal

  • Monoparesis

  • Guarding of the extremity

  • Refusal to walk, pain, agitation

​

ADEM

  • Gradual onset (hours to days)

  • Associated encephalopathy

  • Neurological deficits in varying locations suggesting more than one location of brain involvement

​

Conversion

  • Sensory complains prominent

  • Tone and reflexes normal

​

Hemiplegic migraine

  • Headache or history of migraine

  • History of similar event that resolved

  • Typically strong sensory component

  • Jacksonian onset, (i.e. starts in fingers and travels up arm in a matter of a few minutes)

​

MTX toxicity

  • Onset may be sudden or gradual

  • History of recent MTX (most often IT)

​

Differential diagnosis for new onset seizure

​

Stroke

  • Neonate

  • Persistent weakness of an affected limb after seizure

  • Normal or mildly elevated BP

  • Recent “viral” illness 

  • h/o complex medical disease

​

CSVT

  • Associated encephalopathy

  • Progressive headache or visual disturbance

  • h/o aspariginase, OCP, head/neck infection

        Encephalitis

  • Encephalopathy

  • Subtle onset or gradual development of focal neurological deficits

  • Fever

  Neoplasm

  • +/- gradual onset of deficits

  • History of progressive headaches

​

PRES

  • Associated medical conditions (e.g. Lupus or BMT) or HTN urgency

  • Preceding visual symptoms

  • Encephalopathy present

​​

 

Neurological Examination

PedNIH Stroke Scale (PedNIH SS)

​

Pediatric Stroke Outcome Measure (PSOM)

​​​

​

Outcomes

​

  • Immediate mortality quoted as high as 10-40%

  • Mortality from stroke itself is very low (add references)

  • High neurologic morbidity

  • Only 37% of ischemic stroke survivors have full recovery

  • ~ 40% of children with AIS have moderate-to-severe persistent deficits (add reference)

  • >25% risk of epilepsy as a late complication (add reference)

  • Recurrence: 6-14%

    • Risk is greatest in the first 6 months

    • Increased in the presence of  sickle cell disease, vasculopathy and coagulation abnormalities

    • Increased in the presence of multiple risk factors  (~40%  > 1 risk factor)

    • Mortality rates are 40% for recurrent strokes vs 3% for first AIS

References

​Guidelines

​

​​​​​​​

perinatal stroke.png

Standardized Exams

​

  • PedsNIHSS. Ichord, Rebecca N., et al. "Interrater reliability of the Pediatric National Institutes of Health Stroke Scale (PedNIHSS) in a multicenter study." Stroke 42.3 (2011): 613-617.

​

  • PSOM. Kitchen, Lisa, et al. "The pediatric stroke outcome measure: a validation and reliability study." Stroke 43.6 (2012): 1602-1608.

Hyperacute Therapies

​

bottom of page